PHC Group Executive and Leadership Team

Kay Deguchi, the Chief Executive Officer at PHC Group, directs the overarching corporate strategy and global vision. Overseeing all major business units, the Chief Executive Officer ensures alignment with the company's mission to provide innovative healthcare solutions. This leadership role involves driving market expansion across Asia, Europe, and North America, leveraging the company's expertise in diagnostic services and medical technologies. By fostering strategic partnerships and guiding product development, Kay Deguchi enhances PHC Group's competitive position in both business and consumer sectors. The Chief Executive Officer's focus remains on delivering advanced diagnostic tools and digital health platforms that improve patient outcomes and operational efficiency for healthcare facilities worldwide.

Kyoko Deguchi, the President & Representative & Director & Chief Executive Officer at PHC Group, executes critical strategic initiatives and represents the company's interests. This executive leadership position involves guiding the organization's direction and ensuring robust governance across all operational facets. The President & Representative & Director & Chief Executive Officer champions the company's commitment to advancing healthcare through specialized diagnostic services and innovative solutions. By fostering strong relationships with stakeholders and overseeing key corporate functions, Kyoko Deguchi reinforces PHC Group's global presence in Asia, Europe, and North America. The President & Representative & Director & Chief Executive Officer's mandate includes driving growth and ensuring the delivery of high-quality medical diagnostic products and technologies to healthcare facilities and consumers.

Kaiju Yamaguchi, the Executive Corporate Officer and Chief Financial Officer at PHC Group, manages all financial operations and fiscal strategy. Overseeing global financial planning, budgeting, and investment, the Chief Financial Officer ensures the company's financial health and sustainable growth. This critical role involves managing capital allocation, optimizing financial performance, and maintaining strong relationships with investors and financial institutions across PHC Group's international operations in Asia, Europe, and North America. By implementing rigorous financial controls and driving efficiency, Kaiju Yamaguchi supports the company's expansion in diagnostic services and healthcare solutions. The Chief Financial Officer's strategic insights are vital for navigating market dynamics and securing resources for developing innovative medical technologies and digital health platforms.

Koichiro Sato, the Chief Operating Officer & Head of Diabetes Management Business at PHC Group, directs daily operations and spearheads the diabetes management division. Overseeing the execution of business strategies across all operational units, the Chief Operating Officer ensures seamless delivery of diagnostic services and healthcare solutions. This dual role involves managing the end-to-end lifecycle of diabetes management products and technologies, from development to market deployment across Asia, Europe, and North America. Koichiro Sato drives operational efficiency and innovation, focusing on enhancing the company's comprehensive diagnostic tools and digital platforms. The Chief Operating Officer & Head of Diabetes Management Business's leadership is pivotal in expanding market reach and solidifying PHC Group's position as a provider of advanced medical health solutions.